The increasing popularity of?biosimilars?in treating diseases, such as cancer, autoimmune diseases, blood disorders, and others, and the low cost of biosimilars as compared to?biologics?are some of the major factors driving the market.
This report contains market size and forecasts of Biosimilar Contract Manufacturing in Global, including the following market information:
Global Biosimilar Contract Manufacturing Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Biosimilar Contract Manufacturing market was valued at US$ million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Recombinant Non-glycosylated Proteins Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Biosimilar Contract Manufacturing include Boehringer Ingelheim Biopharmaceuticals GmbH, Lonza, Catalent, Inc., Biocon, IQVIA Inc., AGC Biologics, Samsung Biologics, WuXi Biologics and Element Materials Technology, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Publisher has surveyed the Biosimilar Contract Manufacturing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biosimilar Contract Manufacturing Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Biosimilar Contract Manufacturing Market Segment Percentages, by Type, 2021 (%)
Recombinant Non-glycosylated Proteins
Recombinant Glycosylated Proteins
Global Biosimilar Contract Manufacturing Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Biosimilar Contract Manufacturing Market Segment Percentages, by Application, 2021 (%)
Oncology
Blood Disorders
Growth Hormonal Deficiency
Chronic & Autoimmune Disorders
Rheumatoid Arthritis
Others
Global Biosimilar Contract Manufacturing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Biosimilar Contract Manufacturing Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Biosimilar Contract Manufacturing revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Biosimilar Contract Manufacturing revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Boehringer Ingelheim Biopharmaceuticals GmbH
Lonza
Catalent, Inc.
Biocon
IQVIA Inc.
AGC Biologics
Samsung Biologics
WuXi Biologics
Element Materials Technology
Rentschler Biopharma SE
Avid Bioservices, Inc.
Alcami Corporation, Inc.
Fujifilm Kyowa Kirin Biologics Co., Ltd.
Thermo Fisher Scientific Inc.
Almac Group
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Biosimilar Contract Manufacturing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biosimilar Contract Manufacturing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Biosimilar Contract Manufacturing Overall Market Size
2.1 Global Biosimilar Contract Manufacturing Market Size: 2021 VS 2028
2.2 Global Biosimilar Contract Manufacturing Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Biosimilar Contract Manufacturing Players in Global Market
3.2 Top Global Biosimilar Contract Manufacturing Companies Ranked by Revenue
3.3 Global Biosimilar Contract Manufacturing Revenue by Companies
3.4 Top 3 and Top 5 Biosimilar Contract Manufacturing Companies in Global Market, by Revenue in 2021
3.5 Global Companies Biosimilar Contract Manufacturing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Biosimilar Contract Manufacturing Players in Global Market
3.6.1 List of Global Tier 1 Biosimilar Contract Manufacturing Companies
3.6.2 List of Global Tier 2 and Tier 3 Biosimilar Contract Manufacturing Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Biosimilar Contract Manufacturing Market Size Markets, 2021 & 2028
4.1.2 Recombinant Non-glycosylated Proteins
4.1.3 Recombinant Glycosylated Proteins
4.2 By Type - Global Biosimilar Contract Manufacturing Revenue & Forecasts
4.2.1 By Type - Global Biosimilar Contract Manufacturing Revenue, 2017-2022
4.2.2 By Type - Global Biosimilar Contract Manufacturing Revenue, 2023-2028
4.2.3 By Type - Global Biosimilar Contract Manufacturing Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Biosimilar Contract Manufacturing Market Size, 2021 & 2028
5.1.2 Oncology
5.1.3 Blood Disorders
5.1.4 Growth Hormonal Deficiency
5.1.5 Chronic & Autoimmune Disorders
5.1.6 Rheumatoid Arthritis
5.1.7 Others
5.2 By Application - Global Biosimilar Contract Manufacturing Revenue & Forecasts
5.2.1 By Application - Global Biosimilar Contract Manufacturing Revenue, 2017-2022
5.2.2 By Application - Global Biosimilar Contract Manufacturing Revenue, 2023-2028
5.2.3 By Application - Global Biosimilar Contract Manufacturing Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Biosimilar Contract Manufacturing Market Size, 2021 & 2028
6.2 By Region - Global Biosimilar Contract Manufacturing Revenue & Forecasts
6.2.1 By Region - Global Biosimilar Contract Manufacturing Revenue, 2017-2022
6.2.2 By Region - Global Biosimilar Contract Manufacturing Revenue, 2023-2028
6.2.3 By Region - Global Biosimilar Contract Manufacturing Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Biosimilar Contract Manufacturing Revenue, 2017-2028
6.3.2 US Biosimilar Contract Manufacturing Market Size, 2017-2028
6.3.3 Canada Biosimilar Contract Manufacturing Market Size, 2017-2028
6.3.4 Mexico Biosimilar Contract Manufacturing Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Biosimilar Contract Manufacturing Revenue, 2017-2028
6.4.2 Germany Biosimilar Contract Manufacturing Market Size, 2017-2028
6.4.3 France Biosimilar Contract Manufacturing Market Size, 2017-2028
6.4.4 U.K. Biosimilar Contract Manufacturing Market Size, 2017-2028
6.4.5 Italy Biosimilar Contract Manufacturing Market Size, 2017-2028
6.4.6 Russia Biosimilar Contract Manufacturing Market Size, 2017-2028
6.4.7 Nordic Countries Biosimilar Contract Manufacturing Market Size, 2017-2028
6.4.8 Benelux Biosimilar Contract Manufacturing Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Biosimilar Contract Manufacturing Revenue, 2017-2028
6.5.2 China Biosimilar Contract Manufacturing Market Size, 2017-2028
6.5.3 Japan Biosimilar Contract Manufacturing Market Size, 2017-2028
6.5.4 South Korea Biosimilar Contract Manufacturing Market Size, 2017-2028
6.5.5 Southeast Asia Biosimilar Contract Manufacturing Market Size, 2017-2028
6.5.6 India Biosimilar Contract Manufacturing Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Biosimilar Contract Manufacturing Revenue, 2017-2028
6.6.2 Brazil Biosimilar Contract Manufacturing Market Size, 2017-2028
6.6.3 Argentina Biosimilar Contract Manufacturing Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Biosimilar Contract Manufacturing Revenue, 2017-2028
6.7.2 Turkey Biosimilar Contract Manufacturing Market Size, 2017-2028
6.7.3 Israel Biosimilar Contract Manufacturing Market Size, 2017-2028
6.7.4 Saudi Arabia Biosimilar Contract Manufacturing Market Size, 2017-2028
6.7.5 UAE Biosimilar Contract Manufacturing Market Size, 2017-2028
7 Players Profiles
7.1 Boehringer Ingelheim Biopharmaceuticals GmbH
7.1.1 Boehringer Ingelheim Biopharmaceuticals GmbH Corporate Summary
7.1.2 Boehringer Ingelheim Biopharmaceuticals GmbH Business Overview
7.1.3 Boehringer Ingelheim Biopharmaceuticals GmbH Biosimilar Contract Manufacturing Major Product Offerings
7.1.4 Boehringer Ingelheim Biopharmaceuticals GmbH Biosimilar Contract Manufacturing Revenue in Global Market (2017-2022)
7.1.5 Boehringer Ingelheim Biopharmaceuticals GmbH Key News
7.2 Lonza
7.2.1 Lonza Corporate Summary
7.2.2 Lonza Business Overview
7.2.3 Lonza Biosimilar Contract Manufacturing Major Product Offerings
7.2.4 Lonza Biosimilar Contract Manufacturing Revenue in Global Market (2017-2022)
7.2.5 Lonza Key News
7.3 Catalent, Inc.
7.3.1 Catalent, Inc. Corporate Summary
7.3.2 Catalent, Inc. Business Overview
7.3.3 Catalent, Inc. Biosimilar Contract Manufacturing Major Product Offerings
7.3.4 Catalent, Inc. Biosimilar Contract Manufacturing Revenue in Global Market (2017-2022)
7.3.5 Catalent, Inc. Key News
7.4 Biocon
7.4.1 Biocon Corporate Summary
7.4.2 Biocon Business Overview
7.4.3 Biocon Biosimilar Contract Manufacturing Major Product Offerings
7.4.4 Biocon Biosimilar Contract Manufacturing Revenue in Global Market (2017-2022)
7.4.5 Biocon Key News
7.5 IQVIA Inc.
7.5.1 IQVIA Inc. Corporate Summary
7.5.2 IQVIA Inc. Business Overview
7.5.3 IQVIA Inc. Biosimilar Contract Manufacturing Major Product Offerings
7.5.4 IQVIA Inc. Biosimilar Contract Manufacturing Revenue in Global Market (2017-2022)
7.5.5 IQVIA Inc. Key News
7.6 AGC Biologics
7.6.1 AGC Biologics Corporate Summary
7.6.2 AGC Biologics Business Overview
7.6.3 AGC Biologics Biosimilar Contract Manufacturing Major Product Offerings
7.6.4 AGC Biologics Biosimilar Contract Manufacturing Revenue in Global Market (2017-2022)
7.6.5 AGC Biologics Key News
7.7 Samsung Biologics
7.7.1 Samsung Biologics Corporate Summary
7.7.2 Samsung Biologics Business Overview
7.7.3 Samsung Biologics Biosimilar Contract Manufacturing Major Product Offerings
7.7.4 Samsung Biologics Biosimilar Contract Manufacturing Revenue in Global Market (2017-2022)
7.7.5 Samsung Biologics Key News
7.8 WuXi Biologics
7.8.1 WuXi Biologics Corporate Summary
7.8.2 WuXi Biologics Business Overview
7.8.3 WuXi Biologics Biosimilar Contract Manufacturing Major Product Offerings
7.8.4 WuXi Biologics Biosimilar Contract Manufacturing Revenue in Global Market (2017-2022)
7.8.5 WuXi Biologics Key News
7.9 Element Materials Technology
7.9.1 Element Materials Technology Corporate Summary
7.9.2 Element Materials Technology Business Overview
7.9.3 Element Materials Technology Biosimilar Contract Manufacturing Major Product Offerings
7.9.4 Element Materials Technology Biosimilar Contract Manufacturing Revenue in Global Market (2017-2022)
7.9.5 Element Materials Technology Key News
7.10 Rentschler Biopharma SE
7.10.1 Rentschler Biopharma SE Corporate Summary
7.10.2 Rentschler Biopharma SE Business Overview
7.10.3 Rentschler Biopharma SE Biosimilar Contract Manufacturing Major Product Offerings
7.10.4 Rentschler Biopharma SE Biosimilar Contract Manufacturing Revenue in Global Market (2017-2022)
7.10.5 Rentschler Biopharma SE Key News
7.11 Avid Bioservices, Inc.
7.11.1 Avid Bioservices, Inc. Corporate Summary
7.11.2 Avid Bioservices, Inc. Business Overview
7.11.3 Avid Bioservices, Inc. Biosimilar Contract Manufacturing Major Product Offerings
7.11.4 Avid Bioservices, Inc. Biosimilar Contract Manufacturing Revenue in Global Market (2017-2022)
7.11.5 Avid Bioservices, Inc. Key News
7.12 Alcami Corporation, Inc.
7.12.1 Alcami Corporation, Inc. Corporate Summary
7.12.2 Alcami Corporation, Inc. Business Overview
7.12.3 Alcami Corporation, Inc. Biosimilar Contract Manufacturing Major Product Offerings
7.12.4 Alcami Corporation, Inc. Biosimilar Contract Manufacturing Revenue in Global Market (2017-2022)
7.12.5 Alcami Corporation, Inc. Key News
7.13 Fujifilm Kyowa Kirin Biologics Co., Ltd.
7.13.1 Fujifilm Kyowa Kirin Biologics Co., Ltd. Corporate Summary
7.13.2 Fujifilm Kyowa Kirin Biologics Co., Ltd. Business Overview
7.13.3 Fujifilm Kyowa Kirin Biologics Co., Ltd. Biosimilar Contract Manufacturing Major Product Offerings
7.13.4 Fujifilm Kyowa Kirin Biologics Co., Ltd. Biosimilar Contract Manufacturing Revenue in Global Market (2017-2022)
7.13.5 Fujifilm Kyowa Kirin Biologics Co., Ltd. Key News
7.14 Thermo Fisher Scientific Inc.
7.14.1 Thermo Fisher Scientific Inc. Corporate Summary
7.14.2 Thermo Fisher Scientific Inc. Business Overview
7.14.3 Thermo Fisher Scientific Inc. Biosimilar Contract Manufacturing Major Product Offerings
7.14.4 Thermo Fisher Scientific Inc. Biosimilar Contract Manufacturing Revenue in Global Market (2017-2022)
7.14.5 Thermo Fisher Scientific Inc. Key News
7.15 Almac Group
7.15.1 Almac Group Corporate Summary
7.15.2 Almac Group Business Overview
7.15.3 Almac Group Biosimilar Contract Manufacturing Major Product Offerings
7.15.4 Almac Group Biosimilar Contract Manufacturing Revenue in Global Market (2017-2022)
7.15.5 Almac Group Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Biosimilar Contract Manufacturing Market Opportunities & Trends in Global Market
Table 2. Biosimilar Contract Manufacturing Market Drivers in Global Market
Table 3. Biosimilar Contract Manufacturing Market Restraints in Global Market
Table 4. Key Players of Biosimilar Contract Manufacturing in Global Market
Table 5. Top Biosimilar Contract Manufacturing Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Biosimilar Contract Manufacturing Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Biosimilar Contract Manufacturing Revenue Share by Companies, 2017-2022
Table 8. Global Companies Biosimilar Contract Manufacturing Product Type
Table 9. List of Global Tier 1 Biosimilar Contract Manufacturing Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Biosimilar Contract Manufacturing Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type - Global Biosimilar Contract Manufacturing Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Biosimilar Contract Manufacturing Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Biosimilar Contract Manufacturing Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application - Global Biosimilar Contract Manufacturing Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Biosimilar Contract Manufacturing Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Biosimilar Contract Manufacturing Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region - Global Biosimilar Contract Manufacturing Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Biosimilar Contract Manufacturing Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Biosimilar Contract Manufacturing Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Biosimilar Contract Manufacturing Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Biosimilar Contract Manufacturing Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Biosimilar Contract Manufacturing Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Biosimilar Contract Manufacturing Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Biosimilar Contract Manufacturing Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Biosimilar Contract Manufacturing Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Biosimilar Contract Manufacturing Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Biosimilar Contract Manufacturing Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Biosimilar Contract Manufacturing Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Biosimilar Contract Manufacturing Revenue, (US$, Mn), 2023-2028
Table 30. Boehringer Ingelheim Biopharmaceuticals GmbH Corporate Summary
Table 31. Boehringer Ingelheim Biopharmaceuticals GmbH Biosimilar Contract Manufacturing Product Offerings
Table 32. Boehringer Ingelheim Biopharmaceuticals GmbH Biosimilar Contract Manufacturing Revenue (US$, Mn), (2017-2022)
Table 33. Lonza Corporate Summary
Table 34. Lonza Biosimilar Contract Manufacturing Product Offerings
Table 35. Lonza Biosimilar Contract Manufacturing Revenue (US$, Mn), (2017-2022)
Table 36. Catalent, Inc. Corporate Summary
Table 37. Catalent, Inc. Biosimilar Contract Manufacturing Product Offerings
Table 38. Catalent, Inc. Biosimilar Contract Manufacturing Revenue (US$, Mn), (2017-2022)
Table 39. Biocon Corporate Summary
Table 40. Biocon Biosimilar Contract Manufacturing Product Offerings
Table 41. Biocon Biosimilar Contract Manufacturing Revenue (US$, Mn), (2017-2022)
Table 42. IQVIA Inc. Corporate Summary
Table 43. IQVIA Inc. Biosimilar Contract Manufacturing Product Offerings
Table 44. IQVIA Inc. Biosimilar Contract Manufacturing Revenue (US$, Mn), (2017-2022)
Table 45. AGC Biologics Corporate Summary
Table 46. AGC Biologics Biosimilar Contract Manufacturing Product Offerings
Table 47. AGC Biologics Biosimilar Contract Manufacturing Revenue (US$, Mn), (2017-2022)
Table 48. Samsung Biologics Corporate Summary
Table 49. Samsung Biologics Biosimilar Contract Manufacturing Product Offerings
Table 50. Samsung Biologics Biosimilar Contract Manufacturing Revenue (US$, Mn), (2017-2022)
Table 51. WuXi Biologics Corporate Summary
Table 52. WuXi Biologics Biosimilar Contract Manufacturing Product Offerings
Table 53. WuXi Biologics Biosimilar Contract Manufacturing Revenue (US$, Mn), (2017-2022)
Table 54. Element Materials Technology Corporate Summary
Table 55. Element Materials Technology Biosimilar Contract Manufacturing Product Offerings
Table 56. Element Materials Technology Biosimilar Contract Manufacturing Revenue (US$, Mn), (2017-2022)
Table 57. Rentschler Biopharma SE Corporate Summary
Table 58. Rentschler Biopharma SE Biosimilar Contract Manufacturing Product Offerings
Table 59. Rentschler Biopharma SE Biosimilar Contract Manufacturing Revenue (US$, Mn), (2017-2022)
Table 60. Avid Bioservices, Inc. Corporate Summary
Table 61. Avid Bioservices, Inc. Biosimilar Contract Manufacturing Product Offerings
Table 62. Avid Bioservices, Inc. Biosimilar Contract Manufacturing Revenue (US$, Mn), (2017-2022)
Table 63. Alcami Corporation, Inc. Corporate Summary
Table 64. Alcami Corporation, Inc. Biosimilar Contract Manufacturing Product Offerings
Table 65. Alcami Corporation, Inc. Biosimilar Contract Manufacturing Revenue (US$, Mn), (2017-2022)
Table 66. Fujifilm Kyowa Kirin Biologics Co., Ltd. Corporate Summary
Table 67. Fujifilm Kyowa Kirin Biologics Co., Ltd. Biosimilar Contract Manufacturing Product Offerings
Table 68. Fujifilm Kyowa Kirin Biologics Co., Ltd. Biosimilar Contract Manufacturing Revenue (US$, Mn), (2017-2022)
Table 69. Thermo Fisher Scientific Inc. Corporate Summary
Table 70. Thermo Fisher Scientific Inc. Biosimilar Contract Manufacturing Product Offerings
Table 71. Thermo Fisher Scientific Inc. Biosimilar Contract Manufacturing Revenue (US$, Mn), (2017-2022)
Table 72. Almac Group Corporate Summary
Table 73. Almac Group Biosimilar Contract Manufacturing Product Offerings
Table 74. Almac Group Biosimilar Contract Manufacturing Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Biosimilar Contract Manufacturing Segment by Type in 2021
Figure 2. Biosimilar Contract Manufacturing Segment by Application in 2021
Figure 3. Global Biosimilar Contract Manufacturing Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Biosimilar Contract Manufacturing Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Biosimilar Contract Manufacturing Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Biosimilar Contract Manufacturing Revenue in 2021
Figure 8. By Type - Global Biosimilar Contract Manufacturing Revenue Market Share, 2017-2028
Figure 9. By Application - Global Biosimilar Contract Manufacturing Revenue Market Share, 2017-2028
Figure 10. By Region - Global Biosimilar Contract Manufacturing Revenue Market Share, 2017-2028
Figure 11. By Country - North America Biosimilar Contract Manufacturing Revenue Market Share, 2017-2028
Figure 12. US Biosimilar Contract Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Biosimilar Contract Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Biosimilar Contract Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Biosimilar Contract Manufacturing Revenue Market Share, 2017-2028
Figure 16. Germany Biosimilar Contract Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 17. France Biosimilar Contract Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Biosimilar Contract Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Biosimilar Contract Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Biosimilar Contract Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Biosimilar Contract Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Biosimilar Contract Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Biosimilar Contract Manufacturing Revenue Market Share, 2017-2028
Figure 24. China Biosimilar Contract Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Biosimilar Contract Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Biosimilar Contract Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Biosimilar Contract Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 28. India Biosimilar Contract Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Biosimilar Contract Manufacturing Revenue Market Share, 2017-2028
Figure 30. Brazil Biosimilar Contract Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Biosimilar Contract Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Biosimilar Contract Manufacturing Revenue Market Share, 2017-2028
Figure 33. Turkey Biosimilar Contract Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Biosimilar Contract Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Biosimilar Contract Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Biosimilar Contract Manufacturing Revenue, (US$, Mn), 2017-2028
Figure 37. Boehringer Ingelheim Biopharmaceuticals GmbH Biosimilar Contract Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Lonza Biosimilar Contract Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Catalent, Inc. Biosimilar Contract Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Biocon Biosimilar Contract Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. IQVIA Inc. Biosimilar Contract Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. AGC Biologics Biosimilar Contract Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Samsung Biologics Biosimilar Contract Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. WuXi Biologics Biosimilar Contract Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Element Materials Technology Biosimilar Contract Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Rentschler Biopharma SE Biosimilar Contract Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Avid Bioservices, Inc. Biosimilar Contract Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Alcami Corporation, Inc. Biosimilar Contract Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Fujifilm Kyowa Kirin Biologics Co., Ltd. Biosimilar Contract Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Thermo Fisher Scientific Inc. Biosimilar Contract Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Almac Group Biosimilar Contract Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Global Brain-inspired Computing Market G..
The global market for Brain-inspired Computing is estimated ..
+16467917070US (Toll Free)